Close Menu

NEW YORK (GenomeWeb) – French diagnostic and theranostics firm Theradiag announced on Thursday that it has signed an agreement under which its Lisa Tracker monitoring kits will be referenced in supply contracts for Merck's immunosuppressant Remicade (infliximab) in France.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.